219
Participants
Start Date
February 11, 2019
Primary Completion Date
June 30, 2022
Study Completion Date
June 30, 2022
OKG-0301
OKG-0301 is an experimental ophthalmic antiviral and immunomodulatory therapeutic
Sydney Eye Hospital, Sydney
Albury Eye Clinic, Albury
The Royal Victorian Eye and Ear Hospital, Melbourne E.
The Royal Adelaide Hospital, Adelaide
Lions Eye Institute Day Surgery Centre, Nedlands
Hobart Eye Surgeons, Hobart
Lead Sponsor
Okogen
INDUSTRY